- Home
- HCM vs AIR Comparison
HCM vs AIR Comparison
Compare HCM & AIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- AIR
- Stock Information
- Founded
- HCM 2000
- AIR 1951
- Country
- HCM Hong Kong
- AIR United States
- Employees
- HCM N/A
- AIR N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- AIR Aerospace
- Sector
- HCM Health Care
- AIR Industrials
- Exchange
- HCM Nasdaq
- AIR Nasdaq
- Market Cap
- HCM 2.3B
- AIR 2.1B
- IPO Year
- HCM N/A
- AIR 1988
- Fundamental
- Price
- HCM $13.52
- AIR $67.38
- Analyst Decision
- HCM Hold
- AIR Strong Buy
- Analyst Count
- HCM 1
- AIR 4
- Target Price
- HCM $19.00
- AIR $81.50
- AVG Volume (30 Days)
- HCM 85.0K
- AIR 273.2K
- Earning Date
- HCM 02-26-2025
- AIR 01-07-2025
- Dividend Yield
- HCM N/A
- AIR N/A
- EPS Growth
- HCM N/A
- AIR N/A
- EPS
- HCM N/A
- AIR 0.28
- Revenue
- HCM $610,806,000.00
- AIR $2,571,600,000.00
- Revenue This Year
- HCM N/A
- AIR $19.84
- Revenue Next Year
- HCM $18.76
- AIR $6.19
- P/E Ratio
- HCM N/A
- AIR $238.14
- Revenue Growth
- HCM N/A
- AIR 18.53
- 52 Week Low
- HCM $13.00
- AIR $54.71
- 52 Week High
- HCM $21.92
- AIR $76.34
- Technical
- Relative Strength Index (RSI)
- HCM 40.71
- AIR 49.82
- Support Level
- HCM $13.10
- AIR $65.70
- Resistance Level
- HCM $13.92
- AIR $69.17
- Average True Range (ATR)
- HCM 0.38
- AIR 1.57
- MACD
- HCM 0.02
- AIR -0.40
- Stochastic Oscillator
- HCM 37.96
- AIR 24.17
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About AIR AAR Corp.
AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in three segments namely Parts Supply, Repair & Engineering, and Integrated Solutions. The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts. Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services. Integrated Solutions segment majorly consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense and foreign governments, flight hour component inventory and repair programs for commercial airlines.